Market Place

Market Place

Market Place

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search
All
API
FDF
Price
Services
Excipients
Enquiries

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Price
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    pipeline-prospector-insert-v1
    X

    Find Novel Drugs for Infections and Infectious Diseases under Development in CHINA

    A collaboration with SCORR Marketing

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    News Type filter
      Company filter
        Product Type filter
          Deal Size filter
            Upfront Payment filter
              refresh

              Product Type

              Companies

              BravoVax

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              CHINA China

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              Duphat

              Participation Not Confirmed

              Request a Meeting Now

              GeoVax and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine

              Contact the Supplier

              Lead Product(s): 2019-nCoV vaccine

              Therapeutic Area: Infections and Infectious Diseases

              Highest Development Status: Undisclosed Product Type: Vaccine

              Partner/Sponsor/Collaborator: GeoVax

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Collaboration January 28, 2020

              Details:

              GeoVax will use its MVA-VLP vaccine platform and expertise to design and construct the vaccine candidate and BravoVax will provide further development including testing and manufacturing support.

              WuXi Biologics

              • Development Update

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              CHINA China

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              Duphat

              Participation Not Confirmed

              Request a Meeting Now

              WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus

              Contact the Supplier

              Lead Product(s): Multiple neutralizing antibodies

              Therapeutic Area: Infections and Infectious Diseases

              Highest Development Status: Undisclosed Product Type: Large molecule

              Partner/Sponsor/Collaborator: Not Applicable

              Deal Size: Not Applicable Upfront Cash: Not Applicable

              Deal Type: Not Applicable January 28, 2020

              Details:

              WuXi Biologics has established a 100+ R&D team dedicated to the development and manufacturing of multiple neutralizing antibodies for 2019-nCoV.

              PharmaCompass__DigitalAd